Clinical Trial Update: Intravitreal Aflibercept for Submacular Hemorrhage [Phase 4]

View source ↗

Summary

The document reports the completion of a Phase 4 clinical trial evaluating intravitreal aflibercept for submacular hemorrhage in exudative age-related macular d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Kim's Eye Hospital | Conditions: Exudative Age-related Macular Degeneration | Phase 4 | Status: COMPLETED